Hyperosmolar urea for elective midtrimester abortion. Experience in 1,913 cases

R. T. Burkman; M. F. Atienza; T. M. King; J. A. Tonascia; J. C. Pang; A. J. Whitmore

doi:10.1016/0002-9378(78)90467-2

Hyperosmolar urea for elective midtrimester abortion. Experience in 1,913 cases

R. T. Burkman, M. F. Atienza, T. M. King, J. A. Tonascia, J. C. Pang, A. J. Whitmore

Bloomberg School of Public Health

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Intra-amniotic hyperosmolar urea (59.7 per cent) augmented by intravenous oxytocin (332 mμ per minute), prostaglandin F(2α)(20 mg.), prostaglandin F(2α)(10 mg.), or prostaglandin F(2α)(5 mg.) was utilized for 1,913 patients requesting elective midtrimester abortion. Injection-abortion intervals ranging from 13.70 to 21.49 hours were achieved with failure rates of 0.7 to 6.7 per cent. Despite frequent pre-existing medical conditions, the complication rate compared favorably with those of other methods for terminating midtrimester pregnancy such as saline amnioinfusion or dilatation and evacuation.

Original language	English (US)
Pages (from-to)	10-17
Number of pages	8
Journal	Unknown Journal
Volume	131
Issue number	1
DOIs	https://doi.org/10.1016/0002-9378(78)90467-2
State	Published - 1978

ASJC Scopus subject areas

Obstetrics and Gynecology

Access to Document

10.1016/0002-9378(78)90467-2

Cite this

@article{cd8bde8b452d493f94e67fdbfc321e6a,

title = "Hyperosmolar urea for elective midtrimester abortion. Experience in 1,913 cases",

abstract = "Intra-amniotic hyperosmolar urea (59.7 per cent) augmented by intravenous oxytocin (332 mμ per minute), prostaglandin F(2α)(20 mg.), prostaglandin F(2α)(10 mg.), or prostaglandin F(2α)(5 mg.) was utilized for 1,913 patients requesting elective midtrimester abortion. Injection-abortion intervals ranging from 13.70 to 21.49 hours were achieved with failure rates of 0.7 to 6.7 per cent. Despite frequent pre-existing medical conditions, the complication rate compared favorably with those of other methods for terminating midtrimester pregnancy such as saline amnioinfusion or dilatation and evacuation.",

author = "Burkman, {R. T.} and Atienza, {M. F.} and King, {T. M.} and Tonascia, {J. A.} and Pang, {J. C.} and Whitmore, {A. J.}",

year = "1978",

doi = "10.1016/0002-9378(78)90467-2",

language = "English (US)",

volume = "131",

pages = "10--17",

journal = "Unknown Journal",

issn = "0309-1708",

publisher = "Elsevier Limited",

number = "1",

}

TY - JOUR

T1 - Hyperosmolar urea for elective midtrimester abortion. Experience in 1,913 cases

AU - Burkman, R. T.

AU - Atienza, M. F.

AU - King, T. M.

AU - Tonascia, J. A.

AU - Pang, J. C.

AU - Whitmore, A. J.

PY - 1978

Y1 - 1978

N2 - Intra-amniotic hyperosmolar urea (59.7 per cent) augmented by intravenous oxytocin (332 mμ per minute), prostaglandin F(2α)(20 mg.), prostaglandin F(2α)(10 mg.), or prostaglandin F(2α)(5 mg.) was utilized for 1,913 patients requesting elective midtrimester abortion. Injection-abortion intervals ranging from 13.70 to 21.49 hours were achieved with failure rates of 0.7 to 6.7 per cent. Despite frequent pre-existing medical conditions, the complication rate compared favorably with those of other methods for terminating midtrimester pregnancy such as saline amnioinfusion or dilatation and evacuation.

AB - Intra-amniotic hyperosmolar urea (59.7 per cent) augmented by intravenous oxytocin (332 mμ per minute), prostaglandin F(2α)(20 mg.), prostaglandin F(2α)(10 mg.), or prostaglandin F(2α)(5 mg.) was utilized for 1,913 patients requesting elective midtrimester abortion. Injection-abortion intervals ranging from 13.70 to 21.49 hours were achieved with failure rates of 0.7 to 6.7 per cent. Despite frequent pre-existing medical conditions, the complication rate compared favorably with those of other methods for terminating midtrimester pregnancy such as saline amnioinfusion or dilatation and evacuation.

UR - http://www.scopus.com/inward/record.url?scp=0017873523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017873523&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(78)90467-2

DO - 10.1016/0002-9378(78)90467-2

M3 - Article

C2 - 645773

AN - SCOPUS:0017873523

SN - 0309-1708

VL - 131

SP - 10

EP - 17

JO - Unknown Journal

JF - Unknown Journal

IS - 1

ER -

Hyperosmolar urea for elective midtrimester abortion. Experience in 1,913 cases

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this